ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-5229ometendo-5229Research ArticleСтатьиArticlesИнсулинорезистентность и избыточная масса телау пациентки с пролактинсекретирующей аденомой гипофизаInsulinorezistentnost' i izbytochnaya massa telau patsientki s prolaktinsekretiruyushchey adenomoy gipofizaBarminaI I-DzeranovaL K-DobrachevaA D-Astaf'evaI I-20081512200854№4 (2008)5658Copyright © Barmina I.I., Dzeranova L.K., Dobracheva A.D., Astaf'eva I.I., 20082008Barmina I.I., Dzeranova L.K., Dobracheva A.D., Astaf'eva I.I.Barmina I.I., Dzeranova L.K., Dobracheva A.D., Astaf'eva I.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/5229ReferencesДедов И.И., Мельниченко Г.А., Романцова Т.И. Синдром гиперпролактинемии. - М., 2004.Дедов И.И., Мельниченко Г.А., Романцова Т.И. Синдром гиперпролактинемии. - М., 2004.Курляндская Р.И., Романцова Т.И. Влияние гиперпролактинемии на основные показатели жирового обмена. // Лечащий врач. - 2004. - № 1.Курляндская Р.И., Романцова Т.И. Влияние гиперпролактинемии на основные показатели жирового обмена. // Лечащий врач. - 2004. - № 1.Abech D.D., Moratelli H.B., Leite S.C., Oliveira M.C. Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. // Gynecol Endocrinol. - 2005. - Vol. 21. № 4. - P. 223-236.Abech D.D., Moratelli H.B., Leite S.C., Oliveira M.C. Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. // Gynecol Endocrinol. - 2005. - Vol. 21. № 4. - P. 223-236.Bahceci M., Tuzcu A., Bahceci S., Tuzcu S. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome? // J Endocrinol Invest. - 2003. - Vol. 26. N. 7. - P. 655-659.Bahceci M., Tuzcu A., Bahceci S., Tuzcu S. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome? // J Endocrinol Invest. - 2003. - Vol. 26. N. 7. - P. 655-659.Baptista T., Lacruz A., Meza T., Contreras Q., Delgado C., Mejas M.A., Hernndez L. Antipsychotic drugs and obesity: is prolactin involved? //Can J Psychiatry. - 2001. - Vol. 46. N 9. - P. 829-834.Baptista T., Lacruz A., Meza T., Contreras Q., Delgado C., Mejas M.A., Hernndez L. Antipsychotic drugs and obesity: is prolactin involved? //Can J Psychiatry. - 2001. - Vol. 46. N 9. - P. 829-834.Ben-Jonathan N., Hugo E.R., Brandebourg T.D., LaPensee C.R. Focus on prolactin as a metabolic hormone. // Trends Endocrinol Metab. - 2006. - Vol. 17. № 3. - P. 110-116Ben-Jonathan N., Hugo E.R., Brandebourg T.D., LaPensee C.R. Focus on prolactin as a metabolic hormone. // Trends Endocrinol Metab. - 2006. - Vol. 17. № 3. - P. 110-116Brandebourg T.D., Bown J.L., Ben-Jonathan N. Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue. // Biochem Biophys Res Commun. - 2007. - Vol. 357. № 2. - P. 408-413.Brandebourg T.D., Bown J.L., Ben-Jonathan N. Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue. // Biochem Biophys Res Commun. - 2007. - Vol. 357. № 2. - P. 408-413.Christin-Ma tre S., Delemer B., Touraine P., Young J. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. //Ann Endocrinol (Paris). - 2007 - Vol. 68. № 2-3. - P.106-112.Christin-Ma tre S., Delemer B., Touraine P., Young J. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. //Ann Endocrinol (Paris). - 2007 - Vol. 68. № 2-3. - P.106-112.Doknic M., Pekic S., Zarkovic M., Medic-Stojanoska M., Dieguez C., Casanueva F., Popovic V. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. // Eur J Endocrinol. - 2002. - Vol. 147. № 1. - P. 77-84.Doknic M., Pekic S., Zarkovic M., Medic-Stojanoska M., Dieguez C., Casanueva F., Popovic V. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. // Eur J Endocrinol. - 2002. - Vol. 147. № 1. - P. 77-84.Fleenor D.E., Freemark M. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. // Endocrinology. - 2001. - Vol. 142. № 7. - P. 2805-2810. ЛитератураFleenor D.E., Freemark M. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. // Endocrinology. - 2001. - Vol. 142. № 7. - P. 2805-2810. ЛитератураFleenor D., Arumugam R., Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. // Horm Res. - 2006. - Vol. 66. № 3. - P. 101-110.Fleenor D., Arumugam R., Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. // Horm Res. - 2006. - Vol. 66. № 3. - P. 101-110.Greenman Y., Tordjman K., Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. // Clin Endocrinol (Oxf). - 1998. - Vol.48. № 5. - P. 547-553.Greenman Y., Tordjman K., Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. // Clin Endocrinol (Oxf). - 1998. - Vol.48. № 5. - P. 547-553.Heil S.H. Sex-specific effects of prolactin on food intake by rats. // Horm Behav. - 1999. - Vol. 35. № 1. - P. 47-54.Heil S.H. Sex-specific effects of prolactin on food intake by rats. // Horm Behav. - 1999. - Vol. 35. № 1. - P. 47-54.Ling C., Billig H. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro. // Endocrinology. - 2001. - Vol. 142. № 11. -P.480-490.Ling C., Billig H. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro. // Endocrinology. - 2001. - Vol. 142. № 11. -P.480-490.McAveney K.M., Gimble J.M., Yu-Lee L.-Y. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. // Endocrinology. - 1996. - № 137. - P. 5723-5726.McAveney K.M., Gimble J.M., Yu-Lee L.-Y. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. // Endocrinology. - 1996. - № 137. - P. 5723-5726.Moore B.J., Gerardo-Gettens T., Horwitz B.A., Stern J.S. Hyperprolactinemia stimulates food intake in the female rat. // Brain Res Bull. - 1986. - Vol. 17. № 4. - P. 563-569.Moore B.J., Gerardo-Gettens T., Horwitz B.A., Stern J.S. Hyperprolactinemia stimulates food intake in the female rat. // Brain Res Bull. - 1986. - Vol. 17. № 4. - P. 563-569.Pelkonen R., Nikkil E.A., Grahne B. Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. // Clin Endocrinol (Oxf). - 1982. - Vol. 16. № 4. - P. 383-390.Pelkonen R., Nikkil E.A., Grahne B. Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. // Clin Endocrinol (Oxf). - 1982. - Vol. 16. № 4. - P. 383-390.Tuzcu A., Bahceci M., Dursun M., Turgut C., Bahceci S. Insulin sensitivity and hyperprolactinemia. // J Endocrinol Invest. - 2003. - Vol. 26. № 4. - P. 341-346Tuzcu A., Bahceci M., Dursun M., Turgut C., Bahceci S. Insulin sensitivity and hyperprolactinemia. // J Endocrinol Invest. - 2003. - Vol. 26. № 4. - P. 341-346
The authors declare that there are no conflicts of interest present.